- Standard Insulin Pen Needle
- Safety-engineered Insulin Pen Needle
Pen Needle Market was valued at USD 3,172.9 million in 2022 and is expected to grow at a 12.3% CAGR from 2023 to 2029. Pen needles are pen injections used in the delivery of injectable medicines into the body of a patient. Pen needles are comprised of hollow needles embedded in a plastic body and are available in variety of needle lengths and diameters. The pen needles are most commonly used in the treatment of type I diabetics and type II diabetics for injecting insulin and other types of medications. Thus, the increasing prevalence of diabetes has surged the demand for pen needles and thus expected to drive the growth of pen needle market over the forecast period. For instance, according to the International Diabetes Federation (IDF), 642 million people are estimated to have diabetes by 2040.
In addition, the increasing prevalence of other chronic diseases such as osteoporosis, cardiovascular disease, and multiple sclerosis requires daily or weekly drug administration by the use of pen injectables which is anticipated to drive the growth of the pen injections market over the forecast period. furthermore, due to their simplicity, and reliability pen needles can administer drugs directly by the patients without the aid of a physician, this is expected to boost the growth of the pen needles market over the forecast period. However, the needlestick injuries, pain, infection, and hyperglycemia associated with pen needle administration are expected to hinder the growth of the pen needle market over the forecast period. In addition, changing the preference of patients in alternative modes of drug delivery is anticipated to hold and hinder the growth of pen needle market over the forecast period. Moreover, the growing preference of biosimilar drugs are anticipated to provide opportunities to the market players in the market growth over the forecast period.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The pen needle market is expected to grow over the forecasted period due to the increasing prevalence of chronic diseases such as diabetes, osteoporosis, cardiovascular diseases, and multiple sclerosis across the globe is anticipated to drive the growth of the pen needle market over the forecast period. For instance, according to the World Health Organization, more than a billion people are expected to acquire chronic disorders, and about 650 million people are anticipated to have diabetes by 2040 across the globe. In addition, increasing use of pen needles owing to their easiness, reliability, and simplicity is expected to boost the growth of the pen needle market over the forecast period.
The key segments covered in the pen needles market are: by Type, needle length, end user and geography
Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Ypsomed Holding AG (Switzerland), Terumo Corporation (Japan), HTL-STREFA S.A. (Poland)
The pen needles market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Growing preference for biosimilar drugs across the globe is anticipated to provide opportunities to market players in the growth of pen needle market over the forecast period.
1.Executive Summary |
2.Global Pen Needle Market Introduction |
2.1.Global Pen Needle Market - Taxonomy |
2.2.Global Pen Needle Market - Definitions |
2.2.1. By Product Type |
2.2.2. By Size |
2.2.3. By Application |
2.2.4. By Distribution Channel |
2.2.5. By Region |
3.Global Pen Needle Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Pen Needle Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Pen Needle Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Standard Insulin Pen Needle |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Safety-engineered Insulin Pen Needle |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Pen Needle Market By Size, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. 4mm |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. 5mm |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. 6mm |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. 8mm |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. 10mm |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. 12mm |
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
7.Global Pen Needle Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Type I Diabetes |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Type II Diabetes |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8.Global Pen Needle Market By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Hospital Pharmacies |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Retail Pharmacies & Drug Stores |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Online Pharmacies |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9.Global Pen Needle Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Pen Needle Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Standard Insulin Pen Needle |
10.1.2.Safety-engineered Insulin Pen Needle |
10.2. Size Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.4mm |
10.2.2.5mm |
10.2.3.6mm |
10.2.4.8mm |
10.2.5.10mm |
10.2.6.12mm |
10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Type I Diabetes |
10.3.2.Type II Diabetes |
10.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospital Pharmacies |
10.4.2.Retail Pharmacies & Drug Stores |
10.4.3.Online Pharmacies |
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Pen Needle Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Standard Insulin Pen Needle |
11.1.2.Safety-engineered Insulin Pen Needle |
11.2. Size Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.4mm |
11.2.2.5mm |
11.2.3.6mm |
11.2.4.8mm |
11.2.5.10mm |
11.2.6.12mm |
11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Type I Diabetes |
11.3.2.Type II Diabetes |
11.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospital Pharmacies |
11.4.2.Retail Pharmacies & Drug Stores |
11.4.3.Online Pharmacies |
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
12.Asia Pacific (APAC) Pen Needle Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Standard Insulin Pen Needle |
12.1.2.Safety-engineered Insulin Pen Needle |
12.2. Size Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.4mm |
12.2.2.5mm |
12.2.3.6mm |
12.2.4.8mm |
12.2.5.10mm |
12.2.6.12mm |
12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Type I Diabetes |
12.3.2.Type II Diabetes |
12.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospital Pharmacies |
12.4.2.Retail Pharmacies & Drug Stores |
12.4.3.Online Pharmacies |
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Pen Needle Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Standard Insulin Pen Needle |
13.1.2.Safety-engineered Insulin Pen Needle |
13.2. Size Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.4mm |
13.2.2.5mm |
13.2.3.6mm |
13.2.4.8mm |
13.2.5.10mm |
13.2.6.12mm |
13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Type I Diabetes |
13.3.2.Type II Diabetes |
13.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospital Pharmacies |
13.4.2.Retail Pharmacies & Drug Stores |
13.4.3.Online Pharmacies |
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Pen Needle Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Standard Insulin Pen Needle |
14.1.2.Safety-engineered Insulin Pen Needle |
14.2. Size Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.4mm |
14.2.2.5mm |
14.2.3.6mm |
14.2.4.8mm |
14.2.5.10mm |
14.2.6.12mm |
14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Type I Diabetes |
14.3.2.Type II Diabetes |
14.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospital Pharmacies |
14.4.2.Retail Pharmacies & Drug Stores |
14.4.3.Online Pharmacies |
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Novo Nordisk A/S |
15.2.2.Becton |
15.2.3.Dickinson and Company |
15.2.4.Terumo Corp. |
15.2.5.Owen Mumford Ltd. |
15.2.6.Braun Melsungen AG |
15.2.7.Ulti Med Inc. |
15.2.8.HTL-STREFA |
15.2.9.Allison Medical Inc. |
15.2.10.Artsana S.p.A. |
16. Research Methodology |
17. Appendix and Abbreviations |